Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of generic sitagliptin phosphate 100 mg tablet
TCTR20220621004Phase 1Completed
- Sponsor
- Duopharma Biotech
- Start
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of sitagliptin (2 arms), sponsored by Duopharma Biotech. Primary endpoints: Area under the concentration-time curve and Maximum concentration. Started Sep 2020; status: completed.
02
Drugs
sitagliptin
Beyond the preview
Go deeper on TCTR20220621004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220621004.